Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
about
Forcing versus feedback: epidemic malaria and monsoon rains in northwest IndiaThe potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW IndiaArtemisinin-based combination therapies: a vital tool in efforts to eliminate malariaCombating poor-quality anti-malarial medicines: a call to actionTransmission intensity and drug resistance in malaria population dynamics: implications for climate changePlasmodium falciparum: differential selection of drug resistance alleles in contiguous urban and peri-urban areas of Brazzaville, Republic of CongoBenefits of using multiple first-line therapies against malaria.Parasite threshold associated with clinical malaria in areas of different transmission intensities in north eastern TanzaniaThe dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparumThe effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.Evolutionary biology and the avoidance of antimicrobial resistance.Bioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysisAntimalarial drug resistance: a review of the biology and strategies to delay emergence and spreadVariation in infection length and superinfection enhance selection efficiency in the human malaria parasite.Antimalarials and the fight against malaria in BrazilDecreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance.The impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance.Drug resistance in vectorborne parasites: multiple actors and scenarios for an evolutionary arms race.Measuring resistant-genotype transmission of malaria parasites: challenges and prospects.Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.Declining Transmission and Immunity to Malaria and Emerging Artemisinin Resistance in Thailand: A Longitudinal Study.Evaluation of the Parasight Platform for Malaria Diagnosis.Random, top-down, or bottom-up coexistence of parasites: malaria population dynamics in multi-parasitic settings.Superinfection and the evolution of resistance to antimalarial drugs.Epidemic malaria and warmer temperatures in recent decades in an East African highland.Within-host competition can delay evolution of drug resistance in malariaImplications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical modelThe impact of within-host ecology on the fitness of a drug-resistant parasiteModelling the impact of antimalarial quality on the transmission of sulfadoxine-pyrimethamine resistance inThe Impact of Antimalarial Use on the Emergence and Transmission of Plasmodium falciparum Resistance: A Scoping Review of Mathematical ModelsEmerging implications of policies on malaria treatment: genetic changes in the gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa
P2860
Q21145333-77CC1848-0594-4422-B134-6236CAE7B8A9Q21562247-70A5CE98-366D-473A-B9B0-AD8E6E408481Q24614989-CF50FAF4-DFD7-467C-88F6-954899474AF0Q24658634-0DA8C97E-49E1-47A5-A1FD-4BDB28FBC494Q28475943-6975BE5E-10B0-4F6C-B81E-2296D2E23E6DQ28476554-0E14B3D4-B147-475B-B7A2-153CE6331381Q30483653-FE884B52-FA2B-4C2F-8ABC-3035EE628DEEQ30883674-031D306D-9FC7-4DC4-8CA6-6149D4F9412FQ33897315-CB0D9091-8328-419F-B5DB-7E5D8EA4E424Q34894294-5C57A1B5-7576-41FD-8F61-49A3A17BE365Q35768931-313A0A17-BC2D-4AC7-A75B-430F7989EA04Q35960770-2FFE5CC5-0A95-48FE-B3B2-CCE2F56E8ACFQ36111327-5F3D419E-9155-423F-A4E5-479F55127D2EQ36722524-60177EC0-6899-46EE-9317-E4D0F24A131DQ36914971-6F1EA040-D8E6-4712-B600-32223D2AD228Q37213723-2F5C33BF-6253-4AA1-A8FA-CFD8E457C677Q37323427-C79F8512-73F9-46E8-9970-F6D322FA7369Q37396654-E8126AC5-FC7E-45AF-80AF-ADCCBB3D7516Q38118386-6A0FE624-1B63-43A9-9D37-2A8DB4E4E949Q39198350-423A25B1-893F-434A-8926-6F0EB9C49C24Q39363372-9883584E-67C8-4768-A4E4-C90F6AFD3D31Q41995596-49986E23-A7FF-4773-84EE-2C91892EC5BDQ42319630-86F2B2DD-5AFE-4D07-90F2-EE489A8AD85AQ44148061-F9A6339F-54AF-4C93-80A9-97FFF9403662Q51344705-0B35858D-E07A-4F09-8FFA-A51700D2989AQ51779052-1B23CDC6-4235-4AC3-82B1-F94C382FE06EQ56341998-A56C0C3B-5E1F-4E27-B437-D3106AA4DF70Q56348478-DFFEBC63-587C-4D7C-A48D-7DFE0C1705ACQ56374649-DE82D329-AABE-4358-8490-4351BD75821EQ56440042-F061064A-E522-4DD0-B842-478152E7786CQ57151906-D0755CE2-502E-4D6F-BAF3-6480B2B5992BQ58586501-EA929AA1-EA40-43D2-B127-FD20B08300A3
P2860
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
@en
type
label
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
@en
prefLabel
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
@en
P2860
P356
P1433
P1476
Clinically immune hosts as a refuge for drug-sensitive malaria parasites.
@en
P2093
Maciej F Boni
Ramanan Laxminarayan
P2860
P2888
P356
10.1186/1475-2875-7-67
P577
2008-04-25T00:00:00Z
P5875
P6179
1007104315